The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...

Right now, the FDA has approved the new drug to treat pain from an injury or surgery. Its manufacturer is also testing it for ...

The Food and Drug ... pain signals in peripheral pain-sensing neurons, or nociceptors. These neurons are in the peripheral nervous system, meaning they're not the brain, so they can provide pain ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

Neuropathy pain is hard to ignore, often making everyday tasks feel overwhelming. Many people suffering from this condition ...

Chronic pain is ... pain relief without the risks associated with traditional treatments." Those risks include addiction, which is associated with opioids, one class of drugs prescribed for ...

Gabe Whisnant is Deputy Weekend Editor at Newsweek based in South Carolina. Prior to joining Newsweek in 2023, he directed daily publications in North and South Carolina. As an executive editor ...

all working together to provide the most comfortable and pain-free detox available. The treatment program at Boca Detox Center was carefully developed by medical professionals, addiction ...